As the monkeypox epidemic continues in the United Kingdom, some of those affected have expressed concerns about delays and difficulties in tracking contact and vaccination.
Joel told the Guardian that he sought advice on testing and vaccination after learning that close contact had exposed him to monkeypox and he had developed symptoms. However, Joel said he had difficulty accessing tests in London during the anniversary banking holiday and was refused a vaccine, initially told it was only available to healthcare professionals.
Joel was subsequently confirmed as close contact with a case of monkeypox by the UK’s Health Security Agency (UKHSA) and was told he should have been offered the vaccine. However, the delay meant that he was no longer eligible for the strike. These guidelines suggest that the vaccine should ideally be given within four days of exposure to prevent or reduce the effects of infection, although it may be given to high-risk individuals up to 14 days after exposure to reduce symptoms.
Joel said his trial has caused concern, noting that one concern in the community is whether smallpox could leave permanent scars, adding that with ongoing LGBT events involving anonymous sex, it appears likely that smallpox will continue to spread. spreads. “It took so long [public health bodies] to follow [close contacts] that they will have to go out and effectively vaccinate many at-risk groups to stop this, “he said.
Joel said he was initially told to isolate himself for 21 days, but was unable to do so for financial and mental reasons, noting that he was self-employed and also did not want those he worked with to know that he is bisexual. He subsequently tested positive for monkeypox and was asked to isolate himself until all the scabs had disappeared.
According to UKHSA, individuals who have been tested are usually informed of their results within 24 hours, with contacts identified and followed up as soon as possible and vaccination offered if necessary. However, the agency itself noted challenges, “as most cases report sexual contact with new or casual partners, sometimes in the context of cruise sites or during chemical sex, often when contact details were not available for traceability.”
* Matt, who also lives in London, said he had sex with a man who later contacted him to say he was experiencing symptoms and had been in contact with a confirmed case. When Matt called 111, he was advised to isolate himself for 21 days, but was not offered a vaccine as his contact had yet to be tested and confirmed as a case.
Desperate to get the vaccine before potentially experiencing severe symptoms, he told follow-up that he was in connection with the confirmed case and was vaccinated five days after sexual intercourse.
By the time he was tested three days later, he had five lesions. “The doctor said I had one of the mildest cases he had ever seen, and when I said I had the vaccine, he said it was probably the cause,” Matt said.
But while not critical of the response from health officials, who said he was “doing everything possible with a limited number of doses”, he said he believed UKHSA’s public announcements about the disease needed to change.
“They don’t seem to take into account how fast it can spread in gay men’s networks, where people have many, many sexual partners,” he said.
Adding that he can have up to 20 sexual partners a week before he becomes infected, Matt noted that in spaces such as saunas or cruise bars, few people exchange details.
“If you tell people too much, they will just ignore it. But one thing they could say is, if you’re going to keep having sex with a lot of people, get their phone number so one of you can contact the other, “he said. “This is a short-term change that seems to make a lot of sense.”
Sign up for the First Edition, our free daily newsletter – every weekday morning at 7am BST
UKHSA told the Guardian that in addition to mandatory sick pay, in special circumstances, local authorities can provide discretionary payments to those who isolate themselves to mitigate the transmission to the community of a high-impact infectious disease.
The agency said vaccines are available on a case-by-case basis.
A UKHSA spokesman said: “The decision on whether or not to offer a vaccine in close contact with a confirmed case of monkeypox is clinical, made by trained health teams who carry out detailed assessments on a case-by-case basis. This includes specific details of the individual’s exposure and level of risk. Currently, the Imvanex vaccine is only available for high-risk close contacts and decisions are made on a case-by-case basis.
* Some names have changed.
Add Comment